King Pharmaceuticals KG Incurred but not reported (IBNR) claims liability, net

Segments

General Liability4,098,200,000%—

European Hospital Liability1,391,000,000%—

Commercial Auto Liability715,500,000%—

All other lines551,000,000%—

International313,500,000%—

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Operating cash flow-$15.1M-1,628%

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Net margin131.5%—

Return on equity90.8%—

Debt / equity1.5×—